PDCD1 and melanoma: On a small cohort of anti-PD-1-treated melanoma patients, non-responders showed higher proximity of CD68+ cells to CD8+ T cells as compared to responders, both in pre-treatment and on-treatment biopsies pointing out that the interaction of the myeloid cells with the T cell determines the immunosuppressive role of this type of cells [117].